GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Formation of Fibrin Clot (Clotting Cascade)

pathways : Formation of Fibrin Clot (Clotting Cascade) pathways:

Fullview (zoomIn)


Related Genes to "Formation of Fibrin Clot (Clotting Cascade)" content :

preload


Related products :

Catalog number Product name Quantity
NYBT2G1P Fibrin II beta (Bß 15_42), (T)N_DSK, Fibrin II ß (Bß15_461), Clone T2G1, Mab anti_Human, HRP 0.25 ml.
NYBT2G1 Fibrin II beta (Bß 15_42), (T)N_DSK, Fibrin II ß (Bß15_461), Clone T2G1, Mab anti_Human; WB_ELISA 0.2 ml.
UCBVB660 Fibrin, Inhibitor of Fibrin polymerization, binds to Fibrinopeptide A 25 mg.
26-827 MLF1 is involved in lineage commitment of primary hemopoietic progenitors by restricting erythroid formation and enhancing myeloid formation. It interferes with erythopoietin-induced erythroid termina 0.05 mg
20-272-191782 Fibrin - Mouse monoclonal [UC45] to Fibrin Monoclonal 0.1 mg
NCM-R100 NanoCulture Medium (Qualifed for Spheriod Formation) NanoCulture Media has been qualified to facilite spheriod formation in cultures. NanoCulture Medium M (NCM_M) containing BSA works with a wide ran 2 x 50 ml
NCM-M100 NanoCulture Medium (Qualifed for Spheriod Formation) NanoCulture Media has been qualified to facilite spheriod formation in cultures. NanoCulture Medium M (NCM_M) containing BSA works with a wide ran 2 x 50 ml
NCM-R200 NanoCulture Medium (Qualifed for Spheriod Formation) NanoCulture Media has been qualified to facilite spheriod formation in cultures. NanoCulture Medium M (NCM_M) containing BSA works with a wide ran 4 x 50 ml
NCM-M200 NanoCulture Medium (Qualifed for Spheriod Formation) NanoCulture Media has been qualified to facilite spheriod formation in cultures. NanoCulture Medium M (NCM_M) containing BSA works with a wide ran 4 x 50 ml
SCH-4440-0826 NATIVE HUMAN FIBRIN DEGRADATION PRODUCT Y, Product Type Purified Protein, Specificity FIBRIN DEGRADATION PRODUCT Y, Target Species Human, Host N_A, Format Purified, Isotypes , Applications E, C 0.2 mg
SCH-4440-0626 NATIVE HUMAN FIBRIN DEGRADATION PRODUCT X, Product Type Purified Protein, Specificity FIBRIN DEGRADATION PRODUCT X, Target Species Human, Host N_A, Format Purified, Isotypes , Applications E, C 0.2 mg
4440-0826 NATIVE HUMAN FIBRIN DEGRADATION PRODUCT Y, Product Type Purified Protein, Specificity FIBRIN DEGRADATION PRODUCT Y, Target Species Human, Host N_A, Format Purified, Isotypes , Applications E, C 0.2 mg
4440-0626 NATIVE HUMAN FIBRIN DEGRADATION PRODUCT X, Product Type Purified Protein, Specificity FIBRIN DEGRADATION PRODUCT X, Target Species Human, Host N_A, Format Purified, Isotypes , Applications E, C 0.2 mg
SCH-4440-0456 NATIVE HUMAN FIBRIN DEGRADATION PRODUCT E, Product Type Purified Protein, Specificity FIBRIN DEGRADATION PRODUCT E, Target Species Human, Host N_A, Format Purified, Isotypes , Applications E, C 0.1 mg
4440-0456 NATIVE HUMAN FIBRIN DEGRADATION PRODUCT E, Product Type Purified Protein, Specificity FIBRIN DEGRADATION PRODUCT E, Target Species Human, Host N_A, Format Purified, Isotypes , Applications E, C 0.1 mg
1339-95-3 Carmine fibrin Carmine fibrin 1g
SCH-4440-0276 NATIVE HUMAN FIBRIN DEGRADATION PRODUCT D_MONOMER, Product Type Purified Protein, Specificity FIBRIN DEGRADATION PRODUCT D_MONOMER, Target Species Human, Host N_A, Format Purified, Isotypes , Ap 0.2 mg
4440-0276 NATIVE HUMAN FIBRIN DEGRADATION PRODUCT D_MONOMER, Product Type Purified Protein, Specificity FIBRIN DEGRADATION PRODUCT D_MONOMER, Target Species Human, Host N_A, Format Purified, Isotypes , Ap 0.2 mg
HG060250 TAL(gel-clot)
HG020500 TAL(gel-clot)
HG120030 TAL(gel-clot)
HG120060 TAL(gel-clot)
HG060125 TAL(gel-clot)
HG060030 TAL(gel-clot)
HG020030 TAL(gel-clot)

Pathways :

WP1818: Formation of Fibrin Clot (Clotting Cascade)
WP887: Blood Clotting Cascade
WP460: Blood Clotting Cascade
WP1802: Dissolution of Fibrin Clot
WP272: Blood Clotting Cascade
WP1122: Blood Clotting Cascade
WP775: Blood Clotting Cascade
WP255: Blood Clotting Cascade
WP1009: MAPK Cascade
WP422: MAPK Cascade
WP580: Dauer formation
WP1343: MAPK Cascade
WP1844: MAP kinase cascade
WP251: MAPK Cascade
WP402: ERK1 - ERK2 MAPK cascade
WP1128: MAPK Cascade
WP778: MAPK Cascade
WP1826: GPVI-mediated activation cascade
WP1886: Post-translational modification: gamma carboxylation and hypusine formation
WP446: MAPK Cascade
WP1798: Complement cascade
WP892: MAPK Cascade
WP1819: Formation of Platelet plug
WP1884: Platelet Aggregation (Plug Formation)

Related Genes :
[FGG PRO2061] Fibrinogen gamma chain
[F2] Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain]
[F3] Tissue factor (TF) (Coagulation factor III) (Thromboplastin) (CD antigen CD142)
[] Clotting factor B (EC 3.4.21.85) (Coagulation factor B) [Cleaved into: Clotting factor B light chain; Clotting factor B heavy chain]
[F10 FX] Coagulation factor X (EC 3.4.21.6) (Stuart factor) (Virus-activating protease) (VAP) [Cleaved into: Factor X light chain; Factor X heavy chain; Activated factor Xa heavy chain]
[F9] Coagulation factor IX (EC 3.4.21.22) (Christmas factor) (Plasma thromboplastin component) (PTC) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain]
[F10] Coagulation factor X (EC 3.4.21.6) (Stuart factor) [Cleaved into: Factor X light chain; Factor X heavy chain; Activated factor Xa heavy chain]
[] Thrombin-like enzyme BpirSP27 (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) (Fragment)
[F10] Coagulation factor X (EC 3.4.21.6) (Stuart factor) (Stuart-Prower factor) [Cleaved into: Factor X light chain; Factor X heavy chain; Activated factor Xa heavy chain]
[F10] Coagulation factor X (EC 3.4.21.6) (Stuart factor) [Cleaved into: Factor X light chain; Factor X heavy chain; Activated factor Xa heavy chain]
[] Thrombin-like enzyme BpirSP41 (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) (Fragment)
[FGA] Fibrinogen alpha chain [Cleaved into: Fibrinopeptide A; Fibrinogen alpha chain]
[FGB] Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain]
[] Thrombin-like enzyme stejnobin (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP)
[Fga] Fibrinogen alpha chain [Cleaved into: Fibrinopeptide A; Fibrinogen alpha chain]
[F7] Coagulation factor VII (EC 3.4.21.21) (Proconvertin) (Serum prothrombin conversion accelerator) (SPCA) (Eptacog alfa) [Cleaved into: Factor VII light chain; Factor VII heavy chain]
[Fga] Fibrinogen alpha chain [Cleaved into: Fibrinopeptide A; Fibrinogen alpha chain]
[F7] Coagulation factor VII (EC 3.4.21.21) (Serum prothrombin conversion accelerator) [Cleaved into: Factor VII light chain; Factor VII heavy chain]
[KNG1 BDK KNG] Kininogen-1 (Alpha-2-thiol proteinase inhibitor) (Fitzgerald factor) (High molecular weight kininogen) (HMWK) (Williams-Fitzgerald-Flaujeac factor) [Cleaved into: Kininogen-1 heavy chain; T-kinin (Ile-Ser-Bradykinin); Bradykinin (Kallidin I); Lysyl-bradykinin (Kallidin II); Kininogen-1 light chain; Low molecular weight growth-promoting factor]
[Spn27A CG11331] Serine protease inhibitor 27A (Serpin 27A)
[FN1 FN] Fibronectin (FN) (Cold-insoluble globulin) (CIG) [Cleaved into: Anastellin; Ugl-Y1; Ugl-Y2; Ugl-Y3]
[Fn1] Fibronectin (FN) [Cleaved into: Anastellin]
[Fn1] Fibronectin (FN) [Cleaved into: Anastellin]
[PROS1 PROS] Vitamin K-dependent protein S
[] Thrombin-like enzyme bhalternin (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP)
[casE cas6e ygcH b2756 JW2726] CRISPR system Cascade subunit CasE (EC 3.1.-.-) (CasE endoRNase) (crRNA endonuclease)
[] Thrombin-like enzyme LMR-47 (SVTLE LM-47) (SVTLE LMR-47) (EC 3.4.21.74) (Fibrinogen-clotting enzyme) (Gyroxin analog) (Snake venom serine protease) (SVSP) (Venombin A) (Fragment)
[casA cse1 ygcL b2760 JW2730] CRISPR system Cascade subunit CasA (CRISPR type I-E/Ecoli-associated protein CasA/Cse1) (CRISPR-associated protein CasA/Cse1)
[] Thrombin-like enzyme ancrod (SVTLE) (EC 3.4.21.74) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP) (Venombin A)
[SERPING1 C1IN C1NH] Plasma protease C1 inhibitor (C1 Inh) (C1Inh) (C1 esterase inhibitor) (C1-inhibiting factor) (Serpin G1)

Bibliography :
[34808430] Histophilus somni stimulates bovine monocyte-derived macrophages to release microparticles that increase fibrin clot formation in vitro.
[34032355] Dimers of the platelet collagen receptor glycoprotein VI bind specifically to fibrin fibers during clot formation, but not to intact fibrinogen.
[33804899] Extracellular Vesicle-Associated Tissue Factor Activity in Prostate Cancer Patients with Disseminated Intravascular Coagulation.
[33559534] Analysis of blood clotting with the total thrombus analysis system in healthy dogs.
[33230702] Oral administration of dermatan sulphate reduces venous thrombus formation in vivo: potential use as a formulation for venous thromboembolism.
[33091497] Extracts from Uncaria tomentosa as antiplatelet agents and thrombin inhibitors - The in vitro and in silico study.
[32924712] A gottingen minipig model of radiation-induced coagulopathy.
[32776617] COVID-19 as a Blood Clotting Disorder Masquerading as a Respiratory Illness: A Cerebrovascular Perspective and Therapeutic Implications for Stroke Thrombectomy.
[32506946] Diabetes and atherothrombosis: The circadian rhythm and role of melatonin in vascular protection.